| In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS) N Thomas, R Holm, A Müllertz, T Rades Journal of Controlled Release 160 (1), 25-32, 2012 | 237 | 2012 |
| Supersaturated Self-Nanoemulsifying Drug Delivery Systems (Super-SNEDDS) Enhance the Bioavailability of the Poorly Water-Soluble Drug Simvastatin in Dogs N Thomas, R Holm, M Garmer, JJ Karlsson, A Müllertz, T Rades The AAPS Journal, 1-9, 2013 | 154 | 2013 |
| Suppression of Staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, UM-C162 C Kong, CF Chee, K Richter, N Thomas, N Abd. Rahman, S Nathan Scientific reports 8 (1), 2758, 2018 | 139 | 2018 |
| In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate N Thomas, K Richter, TB Pedersen, R Holm, A Müllertz, T Rades The AAPS Journal, 1-11, 2014 | 114 | 2014 |
| Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm D Dong, N Thomas, B Thierry, S Vreugde, CA Prestidge, PJ Wormald PloS one 10 (6), e0131806, 2015 | 109 | 2015 |
| Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges P Joyce, TJ Dening, TR Meola, HB Schultz, R Holm, N Thomas, ... Advanced drug delivery reviews 142, 102-117, 2019 | 107 | 2019 |
| Characterising lipid lipolysis and its implication in lipid-based formulation development N Thomas, R Holm, T Rades, A Müllertz The AAPS journal 14, 860-871, 2012 | 98 | 2012 |
| Influence of lipid composition and drug load on the In Vitro performance of self‐nanoemulsifying drug delivery systems N Thomas, A Müllertz, A Graf, T Rades Journal of Pharmaceutical Sciences 101 (5), 1721-1731, 2012 | 93 | 2012 |
| A topical hydrogel with deferiprone and gallium-protoporphyrin targets bacterial iron metabolism and has antibiofilm activity K Richter, N Thomas, J Claeys, J McGuane, CA Prestidge, T Coenye, ... Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00481-17, 2017 | 82 | 2017 |
| Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections S Subramaniam, P Joyce, N Thomas, CA Prestidge Advanced drug delivery reviews 177, 113948, 2021 | 80 | 2021 |
| Novel nanostructured solid materials for modulating oral drug delivery from solid-state lipid-based drug delivery systems TJ Dening, S Rao, N Thomas, CA Prestidge The AAPS journal 18, 23-40, 2016 | 74 | 2016 |
| Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in Staphylococcus aureus Small Colony Variants K Richter, N Thomas, G Zhang, CA Prestidge, T Coenye, PJ Wormald, ... Frontiers in cellular and infection microbiology 7, 280, 2017 | 68 | 2017 |
| Oral nanomedicine approaches for the treatment of psychiatric illnesses TJ Dening, S Rao, N Thomas, CA Prestidge Journal of Controlled Release 223, 137-156, 2016 | 60 | 2016 |
| Taking the silver bullet colloidal silver particles for the topical treatment of biofilm-related infections K Richter, P Facal, N Thomas, I Vandecandelaere, M Ramezanpour, ... ACS applied materials & interfaces 9 (26), 21631-21638, 2017 | 59 | 2017 |
| Efficacy of Poly-Lactic-Co-Glycolic Acid Micro- and Nanoparticles of Ciprofloxacin Against Bacterial Biofilms N Thomas, C Thorn, K Richter, B Thierry, C Prestidge Journal of Pharmaceutical Sciences 105 (10), 3115-3122, 2016 | 59 | 2016 |
| Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis‐Related Pseudomonas aeruginosa Biofilms CR Thorn, CS Carvalho‐Wodarz, JC Horstmann, CM Lehr, CA Prestidge, ... Small 17 (24), 2100531, 2021 | 57 | 2021 |
| Rifampicin-loaded mesoporous silica nanoparticles for the treatment of intracellular infections S Subramaniam, N Thomas, H Gustafsson, M Jambhrunkar, SP Kidd, ... Antibiotics 8 (2), 39, 2019 | 57 | 2019 |
| Supersaturated silica-lipid hybrids (super-SLH): An improved solid-state lipid-based oral drug delivery system with enhanced drug loading HB Schultz, N Thomas, S Rao, CA Prestidge European Journal of Pharmaceutics and Biopharmaceutics 125, 13-20, 2018 | 55 | 2018 |
| Nanomaterials enabling clinical translation of antimicrobial photodynamic therapy M Awad, N Thomas, TJ Barnes, CA Prestidge Journal of Controlled Release 346, 300-316, 2022 | 54 | 2022 |
| Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate HB Schultz, TR Meola, N Thomas, CA Prestidge International journal of pharmaceutics 577, 119069, 2020 | 54 | 2020 |
Clive PrestidgeProfessor, Co-Director Centre for Pharmaceutical Innovation,University of South AustraliaVerifisert e-postadresse på unisa.edu.au
